OIRA Conclusion of EO 12866 Regulatory Review
RIN: 0910-AG38 View EO 12866 Meetings | Received Date: 10/19/2015 |
Title: "Tobacco Products" Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act | |
Agency/Subagency: HHS / FDA | Stage: Final Rule |
Concluded Action: Consistent with Change | Concluded Date: 05/04/2016 |
Section 3(f)(1) Significant *: No | |
Legal Deadline: None | Economically Significant **: Yes |
Publication Date: 05/10/2016 | Unfunded Mandates: Private Sector |
Major: Yes | Related To Homeland Security: No |
Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
International Impacts: Yes | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
Pandemic Response: Uncollected | |
|